Imagine

Just for a moment imagine …..

Arcadia has a group of experienced highly skilled technical health scientistswho have demonstrated competence in dealing with difficult phase 3 trials andthe FDA … and they seem to have a good mutual respect for and ability to work with ourgood people at Neuren and after helping boost sales of Daybue might beavailable for a new project

… and together Neuren and Arcadia have a priority reviewvoucher … worth a lot AND if it covers a single drug (example NNZ2591) thenmaybe we can spend it on 4 x Phase 3 trials …..

… and … say we get the first couple of positive responses tothe Phase 2 trials then in a few months Neuren and Arcadia together commit togo after the next 4 x phase 3 trials

That opens up THE BIG ONE …. That’sright …. Phase 1 & 2 for autism spectrum …

There are several major types of autism whichinclude Asperger's syndrome, Rett syndrome, childhood disintegrative disorder,Kanner's syndrome, and pervasive developmental disorder.

Together Arcadia and Neuren havethe people … and Daybue provides the money

There is so much misery in thisworld which NNZ2591 might alleviate

AND

Maybe we get to be the investorswho brought forward the world’s first trillion dollar drug!